Elixinol Wellness Statistics
Total Valuation
FRA:E8M has a market cap or net worth of EUR 1.56 million. The enterprise value is 2.70 million.
| Market Cap | 1.56M |
| Enterprise Value | 2.70M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 276.99M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +105.12% |
| Shares Change (QoQ) | +20.50% |
| Owned by Insiders (%) | 11.21% |
| Owned by Institutions (%) | 19.07% |
| Float | 231.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.35 |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.77 |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.45.
| Current Ratio | 0.92 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.14 |
| Interest Coverage | -13.11 |
Financial Efficiency
Return on equity (ROE) is -28.60% and return on invested capital (ROIC) is -37.28%.
| Return on Equity (ROE) | -28.60% |
| Return on Assets (ROA) | -24.18% |
| Return on Invested Capital (ROIC) | -37.28% |
| Return on Capital Employed (ROCE) | -55.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.10 |
| Inventory Turnover | 2.93 |
Taxes
| Income Tax | -2.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.25% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -56.25% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 37.98 |
| Average Volume (20 Days) | 1 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:E8M had revenue of EUR 8.85 million and -1.15 million in losses. Loss per share was -0.01.
| Revenue | 8.85M |
| Gross Profit | 3.17M |
| Operating Income | -3.11M |
| Pretax Income | -3.15M |
| Net Income | -1.15M |
| EBITDA | -2.90M |
| EBIT | -3.11M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 606,819 in cash and 1.73 million in debt, giving a net cash position of -1.13 million.
| Cash & Cash Equivalents | 606,819 |
| Total Debt | 1.73M |
| Net Cash | -1.13M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.89M |
| Book Value Per Share | 0.02 |
| Working Capital | -307,596 |
Cash Flow
In the last 12 months, operating cash flow was -1.51 million and capital expenditures -15,631, giving a free cash flow of -1.53 million.
| Operating Cash Flow | -1.51M |
| Capital Expenditures | -15,631 |
| Free Cash Flow | -1.53M |
| FCF Per Share | n/a |
Margins
Gross margin is 35.78%, with operating and profit margins of -35.16% and -12.99%.
| Gross Margin | 35.78% |
| Operating Margin | -35.16% |
| Pretax Margin | -35.64% |
| Profit Margin | -12.99% |
| EBITDA Margin | -32.75% |
| EBIT Margin | -35.16% |
| FCF Margin | n/a |
Dividends & Yields
FRA:E8M does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -105.12% |
| Shareholder Yield | -105.12% |
| Earnings Yield | -73.49% |
| FCF Yield | -97.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 2, 2024. It was a reverse split with a ratio of 0.125.
| Last Split Date | Dec 2, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.125 |
Scores
FRA:E8M has an Altman Z-Score of -19.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.3 |
| Piotroski F-Score | 2 |